Reactions Weekly

, Volume 1636, Issue 1, pp 243–243 | Cite as

Nivolumab

Interstitial lung disease: 8 case reports
Case report
  • 21 Downloads

Reference

  1. Kato T, et al. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer. Lung Cancer 104: 111-118, Feb 2017. Available from: URL: http://doi.org/10.1016/j.lungcan.2016.12.016 - JapanCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations